BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35101299)

  • 1. Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance.
    Kashofer K; Regauer S; Reich O; Petru E; Winter E
    Gynecol Oncol; 2022 Apr; 165(1):121-128. PubMed ID: 35101299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquisition of Genetic Aberrations During the Progression of High-Grade Intraepithelial Lesions/Micro-Invasive Squamous Cancers to Widely Invasive Cervical Squamous Cell Cancer.
    Kashofer K; Reich O; Regauer S
    Arch Pathol Lab Med; 2023 Dec; 147(12):1438-1445. PubMed ID: 36800542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precise Classification of Cervical Carcinomas Combined with Somatic Mutation Profiling Contributes to Predicting Disease Outcome.
    Spaans VM; Trietsch MD; Peters AA; Osse M; Ter Haar N; Fleuren GJ; Jordanova ES
    PLoS One; 2015; 10(7):e0133670. PubMed ID: 26197069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different Mutational Landscapes in Human Papillomavirus-Induced and Human Papillomavirus-Independent Invasive Penile Squamous Cell Cancers.
    Ermakov MS; Kashofer K; Regauer S
    Mod Pathol; 2023 Oct; 36(10):100250. PubMed ID: 37353203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clear Cell Squamous Cell Carcinoma of the Maxillary Gingiva Associated with PIK3CA and HRAS Mutations: Report of a Case and Literature Review.
    Hirose K; Shibahara T; Teramoto A; Usami Y; Ono S; Iwamoto Y; Murakami S; Oya K; Uzawa N; Motooka D; Hori Y; Morii E; Toyosawa S
    Head Neck Pathol; 2023 Dec; 17(4):1026-1033. PubMed ID: 37735286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.
    Wright AA; Howitt BE; Myers AP; Dahlberg SE; Palescandolo E; Van Hummelen P; MacConaill LE; Shoni M; Wagle N; Jones RT; Quick CM; Laury A; Katz IT; Hahn WC; Matulonis UA; Hirsch MS
    Cancer; 2013 Nov; 119(21):3776-83. PubMed ID: 24037752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.
    Li J; Xue X; Zhang Y; Ding F; Wu W; Liu C; Xu Y; Chen H; Ou Q; Shao Y; Li X; Wu F; Wu X
    Gynecol Oncol; 2023 Aug; 175():133-141. PubMed ID: 37356314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy.
    Zammataro L; Lopez S; Bellone S; Pettinella F; Bonazzoli E; Perrone E; Zhao S; Menderes G; Altwerger G; Han C; Zeybek B; Bianchi A; Manzano A; Manara P; Cocco E; Buza N; Hui P; Wong S; Ravaggi A; Bignotti E; Romani C; Todeschini P; Zanotti L; Odicino F; Pecorelli S; Donzelli C; Ardighieri L; Angioli R; Raspagliesi F; Scambia G; Choi J; Dong W; Bilguvar K; Alexandrov LB; Silasi DA; Huang GS; Ratner E; Azodi M; Schwartz PE; Pirazzoli V; Stiegler AL; Boggon TJ; Lifton RP; Schlessinger J; Santin AD
    Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22730-22736. PubMed ID: 31624127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.
    Lee SY; Chae DK; Lee SH; Lim Y; An J; Chae CH; Kim BC; Bhak J; Bolser D; Cho DH
    BMC Cancer; 2020 Jul; 20(1):694. PubMed ID: 32718341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of oncogenic mutations in cervical carcinoma using method High Resolution Melting (HRM).
    Wayhelova M; Mikulasova A; Smetana J; Vallova V; Blazkova D; Filkova H; Moukova L; Kuglik P
    Neoplasma; 2016; 63(5):779-88. PubMed ID: 27468883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERBB2 mutation: A promising target in non-squamous cervical cancer.
    Xiang L; Jiang W; Ye S; He T; Pei X; Li J; Chan DW; Ngan HYS; Li F; Tao P; Shen X; Zhou X; Wu X; Yang G; Yang H
    Gynecol Oncol; 2018 Feb; 148(2):311-316. PubMed ID: 29279289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China.
    Liu J; Li Z; Lu T; Pan J; Li L; Song Y; Hu D; Zhuo Y; Chen Y; Xu Q
    BMC Med Genomics; 2022 Nov; 15(1):231. PubMed ID: 36333792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implication of oncogenic somatic mutations in early-stage cervical cancer with radical hysterectomy.
    Watanabe T; Nanamiya H; Kojima M; Nomura S; Furukawa S; Soeda S; Tanaka D; Isogai T; Imai JI; Watanabe S; Fujimori K
    Sci Rep; 2020 Oct; 10(1):18734. PubMed ID: 33127935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic Host Cell Alterations in HPV Carcinogenesis.
    Litwin TR; Clarke MA; Dean M; Wentzensen N
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28771191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The landscape of somatic mutations in Indonesian cervical cancer is predominated by the PI3K pathway.
    Spaans VM; Nyoman Bayu Mahendra I; Purwoto G; Trietsch MD; Osse M; Ter Haar N; Peters AAW; Fleuren GJ; Jordanova ES
    Gynecol Oncol; 2018 Jan; 148(1):189-196. PubMed ID: 29113722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
    Kashofer K; Regauer S
    Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsy of PIK3CA mutations in cervical cancer in Hong Kong Chinese women.
    Chung TKH; Cheung TH; Yim SF; Yu MY; Chiu RWK; Lo KWK; Lee IPC; Wong RRY; Lau KKM; Wang VW; Worley MJ; Elias KM; Fiascone SJ; Smith DI; Berkowitz RS; Wong YF
    Gynecol Oncol; 2017 Aug; 146(2):334-339. PubMed ID: 28587748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TERT promoter hot spot mutations are frequent in Indian cervical and oral squamous cell carcinomas.
    Vinothkumar V; Arunkumar G; Revathidevi S; Arun K; Manikandan M; Rao AK; Rajkumar KS; Ajay C; Rajaraman R; Ramani R; Murugan AK; Munirajan AK
    Tumour Biol; 2016 Jun; 37(6):7907-13. PubMed ID: 26700669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mutant-enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer.
    Qiu W; Tong GX; Manolidis S; Close LG; Assaad AM; Su GH
    Int J Cancer; 2008 Mar; 122(5):1189-94. PubMed ID: 17990317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.
    Xing D; Zheng G; Schoolmeester JK; Li Z; Pallavajjala A; Haley L; Conner MG; Vang R; Hung CF; Wu TC; Ronnett BM
    Am J Surg Pathol; 2018 Jun; 42(6):750-760. PubMed ID: 29505425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.